IL1B and breast cancer: However, as IL-1β silencing in MDA-MB-231 cells does not completely abolish the induction of chemokines in MSCs, we cannot exclude that other factors than IL-1β can be released by metastatic breast cancer cells and could be involved in the stimulation of MSCs.